LRRK2 c.1166G>A ;(p.G389E)

Variant ID: 12-40645331-G-A

NM_198578.3(LRRK2):c.1166G>A;(p.G389E)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial.

Journal Of Parkinson'S Disease
Peterschmitt, M Judith MJ; Saiki, Hidemoto H; Hatano, Taku T; Gasser, Thomas T; Isaacson, Stuart H SH; Gaemers, Sebastiaan J M SJM; Minini, Pascal P; Saubadu, Stéphane S; Sharma, Jyoti J; Walbillic, Samantha S; Alcalay, Roy N RN; Cutter, Gary G; Hattori, Nobutaka N; Höglinger, Günter U GU; Marek, Kenneth K; Schapira, Anthony H V AHV; Scherzer, Clemens R CR; Simuni, Tanya T; Giladi, Nir N; Sardi, Sergio Pablo SP; Fischer, Tanya Z TZ; ,
Publication Date: 2022

Variant appearance in text: LRRK2: G389E
PubMed Link: 34897099
Variant Present in the following documents:
  • jpd-12-jpd212714-s001.pdf
View BVdb publication page